The University of Newcastle and Central Coast Council have partnered to undertake a comprehensive scientific study of ocean outfalls and surrounding marine environments.

Overlapping and worsening social, economic and environmental pressures are making Australian high school students more uncertain about their futures compared to a decade ago, according to new research from the University of Newcastle.

To celebrate International Women's Day, Purai Global Indigenous History Centre hosted a dialogue across and between feminisms and feminists from/of the South.

A groundbreaking paper, published today by the University of Newcastle and Noble Ambition, is challenging the philanthropic industry and calling for action to end on-going power imbalances.

A partnership between the University of Newcastle’s Integrated Innovation Network (I2N) and Central Coast Council, the new Gosford Hub represents a significant milestone in the development of the Central Coast's innovation and startup ecosystem.

No money, no time to cook healthy?  Two leading health organisations have joined forces to help show people in Australia how simple it can be to cook heart-healthy meals on a budget.

Giving primary-school students a chance to teach and lead their younger peers not only strengthens their leadership skills, but also improves wellbeing, classroom engagement and student confidence, a new Australian study has shown.

A new art exhibition has emerged from a four‑year study led by University of Newcastle researcher Associate Professor Hedda Askland, exploring how the Hunter Valley can navigate its post‑mining future.

Hunter Medical Research Institute (HMRI) has unveiled a major upgrade to imaging capabilities with the installation of a new Siemens Healthineers MAGNETOM Cima.X Fit MRI scanner at the Hunter Medical Research Institute Imaging Centre, strengthening the region's capacity for world-class medical research.

Researchers are preparing for the arrival of a new state‑of‑the‑art instrument that will accelerate studies into some of the most aggressive cancers.

Popular GLP-1 and GIP medications, such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) are changing the way obesity and type 2 diabetes are viewed and treated.

Technology created at The University of Queensland, in collaboration with Newcastle researchers, could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions.